RAHWAY, N.J.—
Merck, a research-intensive biopharmaceutical company known as MSD outside of the U.S. and Canada, has announced the completion of the acquisition of
Eyebiotech Limited, a privately held ophthalmology-focused biotechnology company.
Read more...